Daqian Xu

4.7k total citations · 3 hit papers
48 papers, 3.0k citations indexed

About

Daqian Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Daqian Xu has authored 48 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Daqian Xu's work include Cancer, Hypoxia, and Metabolism (8 papers), Mechanisms of cancer metastasis (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Daqian Xu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Mechanisms of cancer metastasis (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Daqian Xu collaborates with scholars based in China, United States and South Korea. Daqian Xu's co-authors include Zhimin Lu, Dongming Xing, Ying Meng, Xueli Bian, Rui Liu, Xu Qian, Xinjian Li, Linyong Du, Fei Shao and Yanhua Zheng and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Daqian Xu

46 papers receiving 3.0k citations

Hit Papers

Lipid metabolism and cancer 2020 2026 2022 2024 2020 2020 2024 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daqian Xu China 26 1.8k 1.2k 509 348 309 48 3.0k
Hai‐long Piao China 26 1.9k 1.1× 862 0.7× 321 0.6× 348 1.0× 236 0.8× 75 2.9k
Frank Weinberg United States 19 2.1k 1.2× 1.2k 1.0× 335 0.7× 540 1.6× 270 0.9× 46 3.3k
Gerta Hoxhaj United States 18 2.7k 1.5× 878 0.7× 383 0.8× 456 1.3× 329 1.1× 24 3.7k
Zachary T. Schafer United States 23 2.2k 1.2× 1.2k 1.0× 333 0.7× 550 1.6× 350 1.1× 43 3.2k
Yexiong Tan China 35 2.3k 1.3× 1.1k 0.9× 575 1.1× 627 1.8× 347 1.1× 77 3.5k
Ping Yang China 32 1.8k 1.0× 1.4k 1.2× 252 0.5× 492 1.4× 325 1.1× 159 3.3k
Le Su China 29 1.5k 0.8× 596 0.5× 379 0.7× 235 0.7× 303 1.0× 139 2.7k
Liankun Sun China 37 2.6k 1.5× 1.1k 0.9× 967 1.9× 506 1.5× 311 1.0× 123 4.1k
Marco Colombi Switzerland 13 1.5k 0.9× 613 0.5× 474 0.9× 309 0.9× 261 0.8× 23 2.5k
Rui Liu China 24 1.5k 0.8× 937 0.8× 203 0.4× 336 1.0× 229 0.7× 93 2.4k

Countries citing papers authored by Daqian Xu

Since Specialization
Citations

This map shows the geographic impact of Daqian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daqian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daqian Xu more than expected).

Fields of papers citing papers by Daqian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daqian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daqian Xu. The network helps show where Daqian Xu may publish in the future.

Co-authorship network of co-authors of Daqian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Daqian Xu. A scholar is included among the top collaborators of Daqian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daqian Xu. Daqian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lao, Mengyi, Xiaozhen Zhang, Zejun Li, et al.. (2025). Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Cancer Communications. 45(8). 1010–1037. 1 indexed citations
3.
Luo, Shudi, Xiaoming Jiang, Zheng Wang, et al.. (2025). Inhibition of Tumor Lipogenesis and Growth by Peptide‐Based Targeting of SREBP Activation. Advanced Science. 12(45). e08111–e08111.
4.
Meng, Ying, Dong Guo, Liming Lin, et al.. (2024). Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation. Nature Metabolism. 6(6). 1092–1107. 49 indexed citations breakdown →
5.
Xu, Daqian, et al.. (2023). Achieving the good thermal-stability and lubricity via a dihydroxy biolubricant from the agro-waste of Codonopsis pilosula. Renewable Energy. 221. 119867–119867. 10 indexed citations
6.
Xu, Daqian, et al.. (2023). Tribological properties and thermal-stability of epoxide-functionalized biolubricant derived from the abandon aerial part of Codonopsis pilosula. Tribology International. 185. 108537–108537. 4 indexed citations
7.
Shao, Fei, Xueli Bian, Juhong Wang, et al.. (2021). Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma. Frontiers in Oncology. 11. 561247–561247. 13 indexed citations
8.
Jiang, Hongfei, Lei Zhu, Daqian Xu, & Zhimin Lu. (2020). A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis. Cancer Communications. 40(9). 389–394. 30 indexed citations
9.
Shao, Fei, Xueli Bian, Hongfei Jiang, et al.. (2020). Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma. European Journal of Cancer. 142. 123–131. 16 indexed citations
10.
Xu, Daqian, Zheng Wang, Yan Xia, et al.. (2020). The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. Nature. 580(7804). 530–535. 260 indexed citations breakdown →
11.
Bian, Xueli, Rui Liu, Ying Meng, et al.. (2020). Lipid metabolism and cancer. The Journal of Experimental Medicine. 218(1). 629 indexed citations breakdown →
12.
Li, Xinjian, Xu Qian, Bin Wang, et al.. (2020). Programmable base editing of mutated TERT promoter inhibits brain tumour growth. Nature Cell Biology. 22(3). 282–288. 117 indexed citations
13.
Qian, Xu, Xinjian Li, Zhumei Shi, et al.. (2019). KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis. Molecular Cell. 76(6). 885–895.e7. 119 indexed citations
14.
Wang, Chenyao, Huafei Wang, Deyi Zhang, et al.. (2018). Phosphorylation of ULK1 affects autophagosome fusion and links chaperone-mediated autophagy to macroautophagy. Nature Communications. 9(1). 3492–3492. 146 indexed citations
15.
Guo, Weiwei, Xue You, Daqian Xu, et al.. (2016). PAQR3 enhances Twist1 degradation to suppress epithelial–mesenchymal transition and metastasis of gastric cancer cells. Carcinogenesis. 37(4). 397–407. 38 indexed citations
16.
Zhang, Yuxue, Chunchun Liu, Yinlong Li, et al.. (2016). Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response. Free Radical Biology and Medicine. 97. 38–49. 22 indexed citations
17.
Zhang, Yuxue, Chunchun Liu, Daqian Xu, et al.. (2014). Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice. Journal of Nutrition. 144(7). 1009–1015. 73 indexed citations
18.
Huang, Heng, Ting Jin, Jing He, et al.. (2012). Progesterone and AdipoQ Receptor 11 Links Ras Signaling to Cardiac Development in Zebrafish. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2158–2170. 11 indexed citations
19.
Jin, Ting, Qiurong Ding, Heng Huang, et al.. (2011). PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparatus. Cell Research. 22(4). 661–676. 35 indexed citations
20.
Xu, Daqian, et al.. (1983). On Peronophythora litchii.. 2(4). 201–206. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026